These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18081151)

  • 21. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.
    Cheung WY; Neville BA; Earle CC
    Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
    Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging.
    Larsen SG; Wiig JN; Emblemsvaag HL; Grøholt KK; Hole KH; Bentsen A; Dueland S; Vetrhus T; Giercksky KE
    Colorectal Dis; 2009 Sep; 11(7):759-67. PubMed ID: 18662240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of neoadjuvant radio-chemotherapy in the treatment of rectal cancer].
    Staudacher C; Di Palo S; Tamburini AM; Vignali A; Orsenigo E
    Ann Ital Chir; 2007; 78(6):493-8. PubMed ID: 18510028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of pre- or postoperative radiochemotherapy on complication following anterior resection with en bloc excision of female genitalia for T4 rectal cancer.
    Szynglarewicz B; Matkowski R; Gisterek I; Forgacz J; Lacko A; Pudelko M; Kornafel J
    Colorectal Dis; 2009 May; 11(4):377-81. PubMed ID: 18637920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant therapy and anastomotic leak after tumor-specific mesorectal excision for rectal cancer.
    Martel G; Al-Suhaibani Y; Moloo H; Haggar F; Friedlich M; Mamazza J; Poulin EC; Stern H; Boushey RP
    Dis Colon Rectum; 2008 Aug; 51(8):1195-201. PubMed ID: 18523823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
    Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
    Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
    Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
    Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
    Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete pathologic response after preoperative rectal cancer chemoradiotherapy.
    Ciccocioppo A; Stephens JH; Hewett PJ; Rieger NA
    ANZ J Surg; 2009 Jun; 79(6):481-4. PubMed ID: 19566874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Survival in locally advanced rectal cancer can be improved. Optimal management with centralized investigation and treatment].
    Palmer G; Holm T
    Lakartidningen; 2010 Sep 1-7; 107(35):2014-7. PubMed ID: 21043185
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a single-institution experience after a median follow-up of 95 months.
    Pucciarelli S; Gagliardi G; Maretto I; Lonardi S; Friso ML; Urso E; Toppan P; Nitti D
    Ann Surg Oncol; 2009 Apr; 16(4):893-9. PubMed ID: 19189187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.
    Berardi R; Maccaroni E; Onofri A; Giampieri R; Bittoni A; Pistelli M; Scartozzi M; Pierantoni C; Bianconi M; Cascinu S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2245-58. PubMed ID: 19640208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preoperative treatment of resectable rectal cancer].
    Lasser P
    Ann Chir; 1998; 52(10):989-92; discussion 993-8. PubMed ID: 9951099
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients.
    Willett CG; Czito BG
    Ann Surg Oncol; 2008 Oct; 15(10):2636-8. PubMed ID: 18663534
    [No Abstract]   [Full Text] [Related]  

  • 40. Complete clinical and pathological response to preoperative short course radiotherapy in T 2 rectal cancer.
    Selvasekar CR; Obeidat S; Simcock P; Khan AU
    Indian J Cancer; 2009; 46(4):350-1. PubMed ID: 19749473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.